Recombinant human erythropoietin therapy in critically ill Jehovah's witnesses

Pharmacotherapy

Volumn 28, Issue 11 PART 1, 2008, Pages 1383-1390

  Ball, Amanda M ^a,c   Winstead, P Shane ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b University of Kentucky   (United States)

^c Basement Silverstein ^*  (United States)

Author keywords

Epogen; Erythropoietin; Hemorrhage; Jehovah's Witness; rHuEPO

Indexed keywords

CYANOCOBALAMIN; FLUOROCARBON; FOLIC ACID; HEMOGLOBIN; HEMOGLOBIN BASED OXYGEN CARRIER; HETASTARCH; IRON; POLYMERIZED HEMOGLOBIN; PROTON PUMP INHIBITOR; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG;

ABDOMINAL DISCOMFORT; ADJUVANT THERAPY; ARTHRALGIA; BACKACHE; BLEEDING; BLOOD CONSERVATION; BLOOD TRANSFUSION; BURN; CARDIOVASCULAR DISEASE; COLON RESECTION; CRITICALLY ILL PATIENT; CRYOANESTHESIA; CRYSTALLOID; DISEASE SEVERITY; DRUG DISTRIBUTION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC SPHINCTEROTOMY; ERYTHROPOIESIS; FEVER; FLU LIKE SYNDROME; FLUID RESUSCITATION; FLUSHING; GASTROINTESTINAL HEMORRHAGE; GENERAL SURGERY; HEADACHE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HEMORRHAGIC SHOCK; HEPATOMEGALY; HUMAN; HYPERTENSION; INFECTION RISK; INJURY; IRON THERAPY; JEHOVAH'S WITNESS; MALAISE; NEPHROTOXICITY; OVERALL SURVIVAL; OXYGEN DELIVERY DEVICE; PHLEBOTOMY; PRIMARY PREVENTION; RELIGION; REVIEW; RISK BENEFIT ANALYSIS; SHELF LIFE; SKIN GRAFT; SPLENOMEGALY; SUPPLEMENTATION; THROMBOCYTOPENIA; THROMBOEMBOLISM; TRAFFIC ACCIDENT; TREATMENT DURATION;

BLOOD SUBSTITUTES; CRITICAL CARE; CRITICAL ILLNESS; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HEMORRHAGE; HUMANS; JEHOVAH'S WITNESSES; MALE; MIDDLE AGED;

EID: 55549118575     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.28.11.1383     Document Type: Review

References (17)

1. Dixon JL. Blood: whose choice and whose conscience? New York State J Med 1988;88:463-4.
2. Kulvatunyou N, Heard SO. Care of the injured Jehovah's Witness patient: case report and review of the literature. J Clin Anesth 2004;16(7):548-53.
3. Koestner JA, Nelson LD, Morris JA Jr, Safcsak K. Use of recombinant human erythropoietin (r-HuEPO) in a Jehovah's Witness refusing transfusion of blood products: case report. J Trauma 1990;30(11):1406-8.
4. Kraus P, Lipman J. Erythropoietin in a patient following multiple trauma. Anaesthesia 1992;47(11):962-4.
5. Collins SL, Timberlake GA. Severe anemia in the Jehovah's Witness: case report and discussion. Am J Crit Care 1993;2(3):256-9.
6. Gilcreast DM, Avella P, Camarillo E, Mullane G. Treating severe anemia in a trauma patient who is a Jehovah's Witness. Crit Care Nurse 2001;21(2):69-72, 75-8, 80-2.
7. Cothren C, Moore EE, Offner PJ, Haenel JB, Johnson JL. Blood substitute and erythropoietin therapy in a severely injured Jehovah's Witness. N Engl J Med 2002;346(14):1097-8.
8. Boshkov LK, Tredget EE, Janowska-Wieczorek A. Recombinant human erythropoietin for a Jehovah's Witness with anemia of thermal injury. Am J Hematol 1991;37(1):53-4.
9. Kim D, Slater H, Goldfarb IW, Hammell EJ. Experience with patients with burns who refuse blood transfusion for religious reasons. J Burn Care Rehabil 1993;14(5):541-3.
10. Wolff M, Fandrey J, Hirner A, Jelkmann W. Perioperative use of recombinant human erythropoietin in patients refusing blood transfusions: pathophysiological considerations based on 5 cases. Eur J Haematol 1997;58(3):154-9.
11. Pousada L, Fiorito J, Smyth C. Erythropoietin and anemia of gastrointestinal bleeding in a Jehovah's Witness [letter]. Ann Intern Med 1990;112(7):552.
12. Walton T, Macon EJ. Erythropoietin use in a Jehovah's Witness patient. Ann Pharmacother 2002;36(4):729-30.
13. Gannon CJ, Napolitano LM. Severe anemia after gastrointestinal hemorrhage in a Jehovah's Witness: new treatment strategies. Crit Care Med 2002;30(8):1893-5.
14. Amgen Manufacturing Ltd. Epogen (epoetin alfa) package insert. Thousand Oaks, CA; 2007.
15. DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Anemias. Pharmacotherapy: a pathophysiologic approach, 5th ed. New York: McGraw-Hill, 2005:1729-45.
16. Stollings JL, Oyen LJ. Oxygen therapeutics: oxygen delivery without blood. Pharmacotherapy 2006;26(10):1453-64.
17. McEvoy GK, ed. Epoetin alfa. In: AHFS drug information 2003. Bethesda, MD: American Society of Health-System Pharmacists, 2003:1460.